Official Title

Medication-assisted psychotherapy: Using ketamine-enhanced RODBT to target neural and behavioral mechanisms of action in emerging adults with moderate to severe depression

Study Details

The purpose of this study is to look at the effectiveness and possible success of combining a type of psychotherapy called Radically Open Dialectical Behavior Therapy (RO DBT) along with an FDA-approved medication called ketamine to possibly provide relief of symptoms of depression.

Principal Investigator

Kirsten Gilbert, PhD

IRB Number



Males and females ages 18-25
Moderate to severe persistent depression
No current or past psychosis

Compensation is provided for time and effort (contact the study team for compensation amount).

Volunteer Information

For more information about this study, contact Volunteer for Health at: